LL-Z-1640-2

N/A

Report date: 2026/03/04 20:01:44

NME

Base Information

Drug NameLL-Z-1640-2

Drug Alias NameF-152A1F-152LL-Z-1640-2C-292

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionTGF-β activated kinase-1 inhibitorsExtracellular-signal-regulated kinase 2 inhibitors

TargetsTGF-β activated kinase-1Extracellular-signal-regulated kinase 2

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesAjinomoto Co Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesAjinomoto Co Inc

Active IndicationsN/A

Inactive IndicationsBacterial Infections

ATC CodeN/A